Kristen Fortney - 25 Sep 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Executive Officer, Director
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
25 Sep 2024
Net transactions value
$0
Form type
3
Filing time
25 Sep 2024, 16:44:43 UTC
Previous filing
27 Sep 2024
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIOA Common Stock 1,210,056 25 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 243,714 $10.27 Direct F1
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 115,650 $7.23 Direct F2
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 115,650 $10.85 Direct F3
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 708,044 $8.39 Direct F4
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 5,955 $3.08 By Spouse F5, F6
holding BIOA Stock Option (Right to Buy) 25 Sep 2024 Common Stock 49,757 $10.27 By Spouse F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on January 16, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date
F3 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F4 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F5 The option became fully vested on June 18, 2022.
F6 Represents an employee stock option directly held by the reporting person's spouse.
F7 The option vested or vests as to 1/120th of the total award monthly, with the first tranche vesting on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the option holder's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.